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Background. Majority of CpG dinucleotides in mammalian genomes tend to undergo DNA methylation, but most CpG islands
are resistant to such epigenetic modification. Understanding about mechanisms that may lead to the methylation resistance of
CpG islands is still very poor. Methodology/Principal Findings. Using the genome-scale in vivo DNA methylation data from
human brain, we investigated the flanking sequence features of methylation-resistant CpG islands, and discovered that there
are several over-represented putative Transcription Factor Binding Sites (TFBSs) in methylation-resistant CpG islands, and
a specific group of zinc finger protein binding sites are over-represented in boundary regions (,400 bp) flanking such CpG
islands. About 77% of the over-represented putative TFBSs are conserved among human, mouse and rat. We also observed the
enrichment of 4 histone methylations in methylation-resistant CpG islands or their boundaries. Conclusions/Significance.
Our results suggest a possible mechanism that certain putative zinc finger protein binding sites over-represented in the
boundary regions of the methylation-resistant CpG islands may block the spreading of methylation into these islands, and
those TFBSs over-represented within the islands may both reinforce the methylation blocking and promote transcription.
Some histone modifications may also enhance the immunity of the CpG islands against DNA methylation by augmenting these
TFs’ binding. We speculate that the dynamical equilibrium between methylation spreading and blocking is likely to be
responsible for the establishment and maintenance of the relatively stable DNA methylation pattern in human somatic cells.
Citation: Fan S, Fang F, Zhang X, Zhang MQ (2007) Putative Zinc Finger Protein Binding Sites Are Over-Represented in the Boundaries of Methylation-
Resistant CpG Islands in the Human Genome. PLoS ONE 2(11): e1184. doi:10.1371/journal.pone.0001184
INTRODUCTION
DNA methylation is one of the most important epigenetic
modifications. In mammalian genomes, DNA methylation occurs
at the cytosine residue in the context 59-CG-39 (CpG dinucleotide)
by virtue of DNA methyltransferases [1]. It has been reported that
DNA methylation plays many important functional roles such as
X-chromosome inactivation [2,3], the establishment and mainte-
nance of tissue-specific gene expression profiles [4–6] as well as
developmental programming regulation [7,8].
In human somatic cells, about 70–80% of CpG dinucleotides
undergo methylation [9]. Unmethylated CpG dinucleotides largely
reside in genomic regions called CpG islands (CGIs) [1]. A CGI is
a region where the CpGs are more dense than the genome average,
commonly defined as a region with length of 200 bp or longer in
which the G+C content is no less than 50% and the ratio of
observed/expected CpGs is larger than 0.6 [10]. Although some
CGIs could be methylated in the imprinted regions [4] or in the
inactive X-chromosome [3,11,12], most CGIs are generally resistant
to DNAmethylation [13].But sofar itis still poorly understood what
mechanisms may lead to the methylation-resistance of these CGIs.
A few biological experiments focusing on some specific genes have
indicated that certain cis- a c t i n ge l e m e n t sc o u l da c ta sb o u n d a r i e st o
protect CGIs from methylation (by binding to the corresponding
TFs), such as Sp1 elements in mouse aprt gene [14,15], the (ATAAA)n
repeated sequences in human GSTP1 gene [16], and Sp1 and CTCF
elements in BRCA1 gene [17]. These elements are not universal, and
it has been observed that the deletion of Sp1 in mouseaprtgene would
not cause aberrant methylation of CGIs [18]. Therefore there must
be some other cis-acting elements performing similar boundary roles
and/or some other mechanisms that may help to resist methylation.
In addition, there is little knowledge about location and length, if
exist, of the protective boundaries around unmethylated CGIs.
In recent years, there emerged some computational works on
the prediction of the methylation status of CpG dinucleotides [19],
CGIs [20,21], and CGI fragments [22,23] based solely on DNA
sequence features . They could reach prediction accuracies around
80%, which partially confirms people’s speculation that there may
exit sequence propensity for genomic DNA methylation.
Inspired by these success, we conducted a further investigation
on the potential flanking sequence features of methylation-resistant
CGIs (referred to as un-methylated or U-CGIs for simplicity) with
a genome-scale methylation profiling dataset from human brain
[24]. We found that certain zinc finger protein binding sites,
including Sp1 and CTCF sites, are over-represented in the
boundary sequences of U-CGIs, and the core region of such
boundaries appears to extend ,400 bp upstream or downstream
from the island. There are also some over-represented cis-acting
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blocking DNA methylation spreading and promoting transcrip-
tion. These results were validated to a certain degree on two other
independent large-scale datasets. The study on a recent genome-
scale histone modification dataset showed the enrichment of the
four histone methylations in the U-CGIs or their boundaries,
which implies that many of the TFs indeed bind to some of their
putative binding sites. Based on our observations on these genome-
scale data, we believe that the dynamical equilibrium hypothesis
proposed for mouse [25] could be generalized to human: during
the de novo methylation process in the genome, repetitive sequences
(such as Alu sequences) act as DNA methylation center. As
methylation spreads towards a CGI, several cis-acting elements in
the boundaries of the CGI can recruit specific DNA binding
proteins, such as Sp1 and CTCF, as battlefronts to prevent DNA
methylation from encroaching into the CGI, and additional cis-
elements within the U-CGI regions can further help reinforcing
the methylation blocking activities. And these enriched histone
methylations will also enhance the immunity of U-CGIs from
methylation by augmenting the TFs’ binding. These opposing
(spreading and blocking) activities would come to a dynamical
equilibrium under a given physiological condition of the cells to
establish the observed genomic methylation patterns.
RESULTS
We got 304 U-CGIs and their corresponding flanking sequences
from the methylation-resistant domains of Rollins et al’s genome-
scale methylation data from human brain (see Materials and
methods for details). Another 210 methylation-prone CGIs
(referred to as methylated CGIs or M-CGIs) and their flanking
sequences were extracted from the methylation-prone domains of
the same data set to serve as the background control samples. We
used these data to explore the cis-element features of U-CGIs and
their flanking sequences that are distinct from those of M-CGIs and
their flanking sequences.
For studying the sequence features, we split U-CGIs, M-CGIs
and their corresponding flanking sequences into several 200 bp-
long fragments (motivated by the average inter-nucleosome
distance) as illustrated in Figure 1, and all samples were aligned
by the two ends of the CpG islands (see Materials and Methods for
details). Then MOTIFCLASS [26] was applied to investigate the
Transcription Factor Binding Site (TFBS) frequencies both in the
fragments of U-CGIs and their flanking sequences. TFBSs used
here are from TRANSFAC 9.4 [27]. We used a two-step
hypothesis test for this study (see Materials and Methods for
details), and obtained all the significantly enriched TFBSs
(Bonferroni-adjusted p-value cutoff 0.01) for each fragment of U-
CGIs and flanking sequences. The enrichment of TFBSs is shown
in Figure 2. In the figure, the region between the two ‘0’s on the x-
axis represents the U-CGI region, the regions outside the two ‘0’s
are the flanking regions, and the y-axis is the number of significant
TFBSs in each fragment. From Figure 2, one can see that there are
many enriched TFBSs in and around the U-CGIs, and they reach
‘‘plateaus’’ around the two ends of U-CGIs. These regions extend
,400 bp upstream and downstream from the U-CGIs.
To study whether these results are sensitive to the choice of p-
value cutoff, we also experimented with other cutoffs. The number
and distribution of significant TFBSs under p-value cutoffs of 0.05
and 0.001 (Bonferroni-adjusted) are shown in Figures S1 and S2 in
Supplementary Materials. One can see that although the specific
number of significant TFBSs in each fragment may vary with the
different cutoffs, the fact that there are some common enriched
TFBSs in U-CGIs and in their nearby flanking sequences remains
to be true. One may further define the 400 bp upstream and
downstream of U-CGIs as the boundary sequences (shown as O1
and P1 regions in Figure 1), as such flanking regions appear to be
more robustly containing the enriched TFBSs.
Over-represented TFBSs in methylation-resistant
CGIs
For extracting the specific TFBSs that are enriched in U-CGIs, we
took TFBSs that are simultaneously significantly enriched in more
than three U-CGI fragments (i.e., half of the counted fragments) as
over-represented TFBSs in U-CGIs. Ten TFBSs satisfy this criterion
and they are listed in Table 1 (their corresponding motif logos are
giveninTableS1inSupplementaryMaterials).Thep-valuesofthese
TFBSs by the two-step test were also listed in Table 1. We looked up
the tissue expression pattern of the transcription factors (TFs)
corresponding to these TFBSs in the database TissueDistribution-
DBs (http://genius.embnet.dkfz-heidelberg.de/menu/tissue_db/).
Of the 10 over-represented TFBSs, 8 have been reported to be
expressed in the brain (shown in the 2nd column of Table 1).
Wechecked the annotations oftheseTFs inSwiss-Prot (http://cn.
expasy.org/), and found that among the 8 TFs reported to be
expressed in human brain, the basic helix-loop-helix domain is
shared by 3 TFs. To study the significance of this observation, we
took the rest non-redundant vertebrate TFs in TRANSFAC 9.4 that
are expressed in human brain as control and compared the number
ofthese TFs that contain thebasichelix-loop-helixdomain(Table 2).
One can see that the fraction of basic helix-loop-helix domain in the
U-CGIs-over-represented TFs is marginally higher than that in the
control TFs (p-value=0.0544 by Fisher’s Exact Test).
To investigate whether there are some novel motifs over-
represented in the U-CGIs, we applied the program DME-b [26]
to search for new motifs and applied the two-step hypothesis test to
get the over-represented ones. After eliminating motifs that were
similar to over-represented TFBSs, we got two over-represented
novel motifs. They are also listed at the bottom of Table 1, and
their logos are listed in supplementary Table S3 together with the
corresponding TRANSFAC TFBSs that are most similar to.
Over-represented TFBSs in the boundaries of U-CGIs
In the boundary regions of U-CGIs, we took the TFBSs that are
both significantly enriched in O1 segment and P1 segment as the
over-represented TFBSs in the boundaries. There are 13 such
TFBSs and they are listed in Table 3 with their corresponding
p-values. Their motif logos are in the supplementary Table S2.
Figure 1. Sketch of the division strategies. We split U&M-CGIs into
several fragments with equal width of 200 bp. As the median length of U-
CGIs are much longer than M-CGIs, there are 6 fragments of U-CGIs (A1,
B1, C1, D1, E1, F1) whereas there are only 2 fragments of M-CGIs (A2 and
F2), and such fragments could cover most of the sequences of U&M-CGIs.
A p p l y i n gt h es a m ed i v i s i o ns t r a t e g yt ot h ef l a n k i n gs e q u e n c e s
corresponding to both U&M-CGIs, we extended 800 bp upstream and
downstream of CGIs, and got fragments of J1, I1, H1, G1, K1, L1, M1, N1,
and J2, I2, H2, G2, K2, L2, M2, N2 respectively. We further define 400 bp
upstream and downstream of U-CGIs (O1, P1) as the boundary sequences
since there are few significant TFBSs outside such regions.
doi:10.1371/journal.pone.0001184.g001
ZNFs May Block DNA Methylation
PLoS ONE | www.plosone.org 2 November 2007 | Issue 11 | e1184The corresponding TFs for 10 of these TFBSs are reported as
expressed in human brain according to TissueDistributionDBs
(also shown in Table 3). By checking the annotation in Swiss-Prot,
7 of these 10 TFs possess zinc finger (C2H2-type) domains
(Table 4). Also the rest non-redundant vertebrate TFs expressed in
human brain are chosen as the control and the number of TFs
with such domain in control set is shown in Table 4. One can see
that the fraction of zinc finger domain in these TFs corresponding
to the over-represented TFBSs in U-CGI boundaries is much
higher than that in the control set (p-value=8.63e-4 by Fisher’s
Exact Test).
We also looked for possible new motifs in the boundaries in the
same way as mentioned in the last section, and got two over-
represented novel motifs in the U-CGIs boundaries. They are listed
atthebottomofTable3,andtheirlogoswiththemostsimilarknown
TFBSs can be found in the supplementary Table S4.
Conservation of the putative TFBSs over-
represented in U-CGIs and in the boundaries
We investigated the sequence conservation of the over-repre-
sented putative TFBSs across human, mouse and rat to examine
how many of these sites are potentially functional (see Materials
and Methods for details). We call a putative binding site
significantly conserved if its p-value is less than 0.01. The
proportion of significantly conserved binding sites among all the
binding sites of each transcription factor is shown in supplemen-
tary Tables S5 and S6. One can see that the average proportion
of significantly conserved binding sites of all over-represented
putative TFBSs is 77.39% (with standard deviation 6.7%), which
suggests that most of these TFBSs are under functional (negative)
selection.
Validation on two independent datasets
Yamada et al [28] profiled the methylation status of CGIs on
human chromosome 21q from peripheral blood leukocytes. From
their data, we got 104 U-CGIs and applied the same procedure to
check the significance of the identified over-represented TFBSs
based on the Rollins et al’s data (see results in Tables S7 and S8 in
Supplementary Materials). It can be seen that 7 of the 10 TFBSs
over-represented in U-CGIs and 10 of the 13 TFBSs over-
represented in boundaries obtained in Rollins et al’s data are again
significantly enriched in this dataset.
Figure 2. The number of significantly over-represented TFBSs in each fragment of U-CGIs and their flanking sequences. The x-axis indicates the
location of fragment relative to the 59 or 39 end of U-CGIs. Fragments insides the two ‘0’s correspond to A1, B1, C1, D1, E1 and F1 of Figure 1, and
fragments that are in the 800 bp upstream and downstream of U-CGIs represent J1, I1, H1, G1 and K1, L1, M1, N1 of Figure 1 respectively. The y-axis is
the number of significantly enriched TFBSs in each fragment. We applied the Bonferroni-adjusted p-value cutoff 0.01 here. The sequences that are
400 bp upstream and downstream of U-CGIs are defined as the boundary sequences.
doi:10.1371/journal.pone.0001184.g002
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PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1184Recently, Schumacher et al [29] reported the profile of
unmethylated sites on human chromosomes 21 and 22 in the
brain tissue of eight adults. We extracted 61 U-CGIs from their
unmethylated regions and applied our method (see results in
Tables S9 and S10 in Supplementary Materials). It can be seen
that 8 of the 10 over-represented TFBSs in U-CGIs and 9 of the
13 over-represented TFBSs in boundaries obtained in Rollins et
al’s data are also significantly enriched.
From the results on these two independent datasets, we can see
that most over-represented TFBSs identified in Rollins et al’s data
are indeed enriched in all three independent data sets, suggesting
that the existence of those putatively functional cis-acting elements
in and around U-CGIs is robust and ubiquitous (largely
independent of the examined tissue types).
The influence of U-CGI localization preference
As is known, most of the U-CGIs are positioned at the 59 end of
human genes[1], which is also true for our dataset: 297 of the 304
U-CGIs are located in the promoter regions, while only 79 of the
210 M-CGIs are in promoter regions. It is necessary to check
whether these over-represented cis-elements may simply reflect the
difference between promoter-CGI (CGI located in promoter) and
non-promoter-CGI (CGI not located in promoter) (see Materials
and Methods for details). Results show that there is no clear
boundary in the flanking region of the promoter related CGIs
(Figure 3). There are still 3 over-represented TFBSs (V$HEN1_01,
V$AP4 and V$HEB_Q6) in the promoter related CGIs in at least
5 of the experiments. However, when we changed the definition of
over-represented TFBSs to be TFBSs that are significantly
enriched in all the 6 U-CGI fragments, the first three TFBSs in
Table 1 are still over-represented in the U-CGIs, while there is no
over-represented TFBS in the 10 groups of promoter related
CGIs. In summary, it is unlikely that the observed TFBSs over-
represented in and around U-CGIs are merely caused by the
Table 1. Over-represented TFBSs and other novel motifs in U-CGI fragments.
..................................................................................................................................................
Over-represented TFBS Expressed in human brain* A1 B1 C1 D1 E1 F1
V$KROX_Q6 Y 4.23e-07 1.75e-14 1.35e-17 4.96e-20 2.04e-18 6.24e-11
0.000 0.000 0.000 0.000 0.000 0.000
V$SP1_01 Y 6.65e-09 1.33e-11 1.78e-10 2.66e-13 1.27e-10 4.07e-10
0.000 0.001 0.003 0.000 0.000 0.000
V$HEN1_01 Y 1.81e-10 2.62e-08 1.78e-10 1.35e-07 5.41e-07 1.12e-08
0.000 0.001 0.006 0.001 0.003 0.002
V$CACBINDINGPROTEIN_Q6 N 2.71e-05 1.54e-06 1.83e-05 2.09e-05 1.67e-12 8.08e-08
0.000 0.000 0.000 0.003 0.000 0.000
V$PTF1BETA_Q6 N 5.90e-13 2.23e-08 3.25e-04 5.32e-12 7.41e-08 3.59e-16
0.000 0.000 0.091 0.000 0.005 0.000
V$AP4_01 Y 2.92e-12 2.73e-09 2.80e-06 1.71e-05 3.95e-08 7.75e-13
0.000 0.002 0.014 0.012 0.001 0.000
V$DR1_Q3 Y 1.14e-14 1.72e-08 7.77e-05 4.93e-05 1.92e-07 1.29e-11
0.000 0.000 0.022 0.013 0.000 0.000
V$ELK1_01 Y 4.20e-12 4.83e-10 1.78e-05 3.89e-08 6.21e-06 1.12e-11
0.000 0.000 0.033 0.001 0.015 0.000
V$PPAR_DR1_Q2 Y 7.82e-09 6.29e-09 1.49e-03 7.81e-05 2.07e-07 1.40e-10
0.000 0.000 0.218 0.087 0.009 0.003
V$HEB_Q6 Y 2.90e-06 2.62e-08 2.01e-04 2.11e-05 3.21e-04 8.13e-08
0.000 0.001 0.022 0.000 0.140 0.000
DME_CGI_1 - 1.98e-08 1.51e-13 6.16e-22 2.70e-14 3.12e-03 2.55e-09
0.001 0.000 0.000 0.000 0.009 0.000
DME_CGI_2 - 1.55e-08 4.51e-06 2.56e-20 5.10e-04 2.84e-8 3.86e-19
0.000 0.000 0.000 0.003 0.001 0.000
We use matrix entry of TRANSFAC which could be mapped uniquely to denote TFBS in the first column, and similarly in the tables hereinafter. The second column
indicates whether the TFs corresponding to the over-represented TFBSs have been reported to express in human brain. The two numbers in the 3th–8th columns are
the p-values in the two-step hypothesis test in the corresponding fragment (we use p1 and p2 to represent the upper and lower value respectively). Only the TFBS with
p1 less than Bonferroni-adjusted p-value cutoff 0.01 and p2 less than 0.01 is regarded as a significantly enriched TFBS in the fragment, and is marked in bold. Here we
regard TFBSs or novel motifs that are simultaneously significant in more than 3 U-CGI fragments as over-represented TFBSs or over-represented novel motifs in U-CGIs.
*Y: The TF corresponding to the TFBS has been reported to express in human brain; N: The TF corresponding to the TFBS has not been reported to express in human
brain; -: No information about the TF corresponding to the motif.
Similarly in the tables hereinafter.
doi:10.1371/journal.pone.0001184.t001
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Table 2. The number of TFs with specific domains.
......................................................................
Domain TFs in U-CGIs TFs in control
Basic helix-loop-helix domain 3 9
Others 5 82
We list the number of TFs with basic helix-loop-helix domain and other domains
in U-CGIs and control set.
doi:10.1371/journal.pone.0001184.t002
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ZNFs May Block DNA Methylation
PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1184difference between the CGIs in promoter and non-promoter,
although this possibility could not be completely ruled out. As
a matter of fact, positioning in the promoter region is one
important feature of U-CGIs themselves. It is possible that more
U-CGIs could be promoter related as many more promoters are
still being discovered each day.
For our promoter related U-CGIs, one could see that the
number of over-represented TFBSs in the 59 and 39 end of U-
CGIs is nearly symmetrical (Figure 2). This is reasonable because
we found that 72.4% (220 out of 304) of U-CGIs are located in
bidirectional promoters (promoters shared by pairs of genes that
flank them on the opposite strands). To study whether the
symmetry also exists for U-CGIs located in the unidirectional
promoters, we extracted the 71 U-CGIs located in unidirectional
promoters on the positive strand and observed the similar
symmetric distribution of the over-represented TFBSs (See Figure
S3 in Supplementary Materials). Therefore, without loss of
statistical power, we analyzed all the U-CGIs without subdividing
the directions of their related promoters.
Other chromatin marks mapped to the U-CGIs and
their boundaries
AlargepartoftheTFscorrespondingtotheover-representedTFBSs
act as activators, which could recruit co-activator complexes (such as
chromatin-remodeling complexes, histone-modification enzymes) to
modify the chromatin structure[30,31]. It is interesting to study
whether there are any correlated chromatin marks inside the U-
CGIs and their boundaries. Currently there is only one high-
resolution genome-scale profiling about histone modifications in
human, which detected 20 histone methylations in T cells[32]. It has
been reported that many tissues have similar DNA methylation
landscapes, especially in CGIs[11,12,23]. Therefore, we investigated
the intensities of the 20 histone modification marks in each fragment
of the U- and M-CGIs and their flanking sequences. The average
differences of the 20 histone marks between U-CGIs and M-CGIs
are shown in Figure 4. One could see that H3K4me1, H3K4me2,
H3K4me3 and H3K9me1, all of which were reported to be
positively correlated with transcriptional levels[32–34], are enriched
in boundary regions (H3K4me3 is also enriched inside U-CGIs). A
morerecentChIP-seqstudyhasfurtherconfirmedthatCTCFmarks
boundaries of histone methylation domains [32]. The results imply
that the U-CGIs and their boundaries may physically correspond to
active chromatin domains and their barriers, many of the enriched
ZF TFs may help recruiting chromatin-remodeling factors during
the establishment and/or maintenance of the U-CGIs that are
refractory to DNA methylation.
DISCUSSION
Of all the over-represented cis-acting elements in the boundaries of
the U-CGIs, some of the corresponding TFs have been reported to
prevent DNA methylation from spreading; while others still need
to be further experimentally validated. In [14,35], Brandeis et al
and Mummaneni et al reported that Sp1 elements act as a barrier
to impede the spreading of DNA methylation, later Sp1 and
CTCF elements were observed to be boundary elements to
maintain the methylation free state of BRCA1 promoter in normal
breast tissue [17]. CTCF is a transcriptional regulator with 11 zinc
finger domains which exerts versatile function including re-
pression, activation and chromatin insulation. Its methylation-
dependent binding plays important roles in the regulation of
imprinted genes (H19/Igf2) [36] and in X-chromosome inactiva-
tion [37]. Consistent with these observations, Sp1 and CTCF
elements are both over-represented in our boundary regions.
However the previously reported (ATAAA)n boundary elements
are not observed in our data, they are mostly found in repetitive
Table 3. Over-represented TFBSs and other novel motifs in
boundary sequences.
......................................................................
Over-represented TFBS
Expressed in
human brain O1 P1
V$MAZR_01 Y 8.42e-09 3.32e-12
0.000 0.000
V$CTCF Y 2.16e-08 5.73e-08
0.000 0.000
V$ETF_Q6 N 3.81e-08 2.06e-12
0.000 0.000
V$AP2_Q3 Y 5.81e-08 3.42e-07
0.000 0.000
V$SPZ1_01 Y 2.03e-07 2.28e-08
0.002 0.000
V$KROX_Q6 Y 1.65e-06 2.10e-09
0.000 0.000
V$CACBINDINGPROTEIN_Q6 N 3.52e-06 1.92e-05
0.000 0.000
V$NFKB_Q6 Y 8.81e-06 4.68e-06
0.000 0.000
V$TFIII_Q6 Y 2.04e-05 9.12e-08
0.000 0.000
V$MINI19_B N 2.10e-05 2.88e-06
0.001 0.000
V$GC_01 Y 3.61e-05 1.55e-06
0.000 0.000
V$SP3_Q3 Y 5.20e-05 2.93e-07
0.000 0.000
V$SP1_01 Y 5.22e-05 1.92e-08
0.000 0.000
DME_Boundary_1 - 3.80e-6 4.17e-8
0.000 0.000
DME_Boundary_2 - 1.04e-5 1.08e-5
0.000 0.000
The second column indicates whether the TFs corresponding to the over-
represented TFBSs have been reported to express in human brain. The two
numbers in the 3th–4th columns are the p-values in the two-step hypothesis
test in the corresponding fragment (we use p1 and p2 to represent the upper
and lower value respectively). Only the TFBS with p1 less than Bonferroni-
adjusted p-value cutoff 0.01 and p2 less than 0.01 is regarded as a significant
TFBS in the fragment, and is marked in bold. Here we regard TFBSs or novel
motifs that are both significant in O1 and P1 fragments as the over-represented
TFBSs or over-represented novel motifs in boundaries of U-CGIs.
doi:10.1371/journal.pone.0001184.t003
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Table 4. The number of TFs with specific domains.
......................................................................
Domain TFs in boundaries TFs in control
Zinc finger C2H2-type domain 7 15
Others 3 74
We list the number of TFs with zinc finger C2H2-type domain and other
domains in boundaries and control set.
doi:10.1371/journal.pone.0001184.t004
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PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1184heterochromatin regions that are under represented by the current
human genome assembly. For the rest 11 TFBSs besides Sp1 and
CTCF elements, there have been no reports about their potential
roles in preventing methylation (notice that some of the TFBSs
may be related, such as V$SP1, V$GC_01 and V$KROX_Q6
(reverse complement)). Furthermore, the Egr family corresponding
to matrix V$KROX_Q6 has been recognized to be sensitive to
methylation [38], and Sp3 corresponding to V$SP3 belongs to the
same family with Sp1. Thus, it is possible that such TFBSs may
have similar boundary functions. What is most surprising is that,
70% of the trans-acting factors corresponding to over-represented
TFBSs in the boundaries of U-CGIs possess zinc finger (C2H2-
type) DNA binding domains comparing to only 17% in control set
(Table 4), and 74% of these putative binding sites are found in the
evolutionarily conserved regions. Therefore, we suggest that these
zinc finger DNA binding proteins are likely to play essential roles
in blocking the spreading of DNA methylation and protecting the
U-CGIs from being methylated.
Among the over-represented TFBSs within the U-CGIs, some
of them are also present in the boundary sequences, e.g.
V$SP1_01. HEN1 which is related to V$HEN1_01 and the latter
is known to methylate microRNAs in plants [39], and thus may in
turn protect nearby sequences from methylation in plants since
DNA methylation in plants could be directed by such microRNAs
[40]. But till now, there is neither a clear demonstration that
RNA-directed de novo methylation exists in mammals [40], nor is
there an evidence that HEN1 could methylate microRNAs in
mammals. Although many cis-acting elements in U-CGIs had
been reported to be methylation sensitive, the understanding of
their specific function is still controversial. Some reported that Sp1
elements in U-CGIs mask CGIs from de novo methylation directly
[14] which would enhance the blocking function; others reported
that Sp1 elements in U-CGIs are required for transcription and
may only assist the unmethylation status indirectly [35]. We
investigated the function annotations of TFs corresponding to the
over-represented TFBSs in U-CGIs from Swiss-Prot. It turned
out that 75% of them are annotated as activator, comparing to
50% in those over-represented in boundaries and 43% in the
control TFs. Such TFs in U-CGIs should be closely related to
activation of gene expression, which is consistent with earlier
reports [4,41]. Combining with the results that some over-
represented TFBSs in U-CGIs are also present in boundary
regions, we believe that these over-represented cis-acting elements
in U-CGIs may have dual functions: they may help protecting U-
CGIs against methylation, at the same time can also promote
transcription [35].
Figure 3. The number of significantly over-represented TFBSs in each fragment of promoter related CGIs and their flanking sequences. The x-
axis indicates the location of fragment relative to the 59 or 39 end of CGIs. The y-axis is the average number of significant TFBSs in each fragment in
the 10 experiments. One can see that there is no clear boundary in the flanking region of promoter related CGIs.
doi:10.1371/journal.pone.0001184.g003
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PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1184It has been reported that H3K4 methylation coincides with
CGIs to remarkable extent [42]. The targeting of the modification
enzymes to the specific sites is largely dependent on gene-specific
transcription factors [43]. The zinc finger proteins corresponding
to the over-represented TFBSs might be co-regulators of the 4
enriched histone methylations. On the other hand, the histone
modifications positively correlated with transcriptional levels have
the potential to unfold chromatins, which can further strengthen
the TFs’ binding. The higher the probability of TFs’ binding is, the
stronger the methylation-protection function will be. DNA
methylation and histone modifications are two important factors
in the complex regulatory network modulating chromatin
structure and genome function[44]. The correlation between the
transcription factors, histone modification and CGI methylation
observed in this study may reveal a clue on how the factors interact
with each other in the complex network.
We also investigated whether there were some over-represented
TFBSs in M-CGIs and their 400 bp flanking regions. Applying the
same two-step hypothesis test on A2 vs. A1, F2 vs. F1, O2 vs. O1
and P2 vs. P1, we also got some over-represented TFBSs (see
supplementary Tables S11 and S12). But there is no enriched
chromatin marks in or around M-CGIs from Figure 4. Whether it
is possible that the lacking of these TFBSs in the U-CGIs and in
the boundaries may also contribute to methylation resistance can
be an interesting topic for further investigations.
In mammalian genomes, methylation pattern is established by
several steps during development [7]. Firstly, most of methyl
groups are erased after fertilization [45]. Gametes will then
undergo de novo methylation at about the time of implantation [46],
and herefrom methylation pattern will be preserved by mainte-
nance methylation during lifetime [47]. In the mouse, a hypothesis
based on the aprt gene was proposed that methylation preferen-
tially targets to specific sequences called methylation center in the
de novo methylation stage [15], such as B1 repetitive elements [25];
then methylation will spread to their surrounding sequences till
some cis-acting sequences block its spreading [15], and such
barrier would explain the existence of the U-CGIs [40].
In the genome-wide U-CGIs obtained from human brain DNA,
sequences adjacent to the unmethylation domains are occupied by
AluS and AluY families which are highly methylated [24]. In
addition, we found that there are boundary regions of 400 bp both
in the 59 and 39 end of U-CGIs over-represented with a group of
zinc finger protein binding sites. Thus, we infer that the protection
mechanism in the formation of U-CGIs based on mouse aprt gene
is also applicable to human: Alu elements may function as the
methylation centers [48]; when methylation moves forward their
Figure 4. The average differences of histone modifications between U and M fragments. The x-axis indicates the location of fragment relative to
the 59 or 39 end of CGIs. The y-axis is the differential average intensity in each fragment. One can see that H3K4me1, H3K4me2 and H3K9me1are
enriched in boundary regions, and H3K4me3 is enriched both in the U-CGIs and their boundaries.
doi:10.1371/journal.pone.0001184.g004
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PLoS ONE | www.plosone.org 7 November 2007 | Issue 11 | e1184surrounding sequences, cis-acting elements bound with specific
zinc finger proteins will block its spreading, and methylation
pattern stabilizes when such counter-act reaches to a dynamical
equilibrium. When some external condition changes, the dynam-
ical equilibrium may be reestablished and the range of the
methylation-resistant regions would move back and forth along the
DNA sequences. For example, if some of the cis-acting elements
are mutated (or methylation enzymes are mutated or their
concentration levels are changed), the blocking capacity may be
weakened or even dysfunctional, which would cause the U-CGIs
to be gradually methylated. Similar observations have been
reported in [14,35]. Therefore, aberrant methylation of tumor-
suppressor genes and progressive methylation in some tissue
during aging may be explained by the weakening of the protection
mechanism [49]. In our data, one U-CGI is in the promoter
region of MT1A with Alu sequences in the 59 flanking region.
MT1A gene was reported to be methylation-free in normal tissue
but hypermethylated to varying extent in some cancers [50,51].
We speculate that a shifting of the dynamical equilibrium may
contribute to the aberrant methylation.
MATERIALS AND METHODS
Datasets
Our dataset is from Rollins et al [24], which detects the in vivo DNA
methylation landscape of human brain. By digestion the sequences
with McrBC (Rm
5C-N40–500-Rm
5C) and another five restriction
endonucleases (REs): Tail (ACGT), BstUI (CGCG), HhaI
(GCGC), HpaII (CCGG), and Acil (CCGC and GCGG), they
identified 4240 methylation-resistant domains and 3518 methyl-
ation-prone domains respectively. According to the definition of
CGI in UCSC Genome Browser: minimum length 200 bp, G+C
content $50% and observed/expected CpG ratio $0.6 [10], we
extracted 304 U-CGIs from methylation-resistant domains and
210 M-CGIs in methylation-prone domains as our background
sequences. The median lengths of U-CGIs and M-CGIs are
886 bp and 275 bp respectively. To identify over-represented
TFBSs, we used 146 non-redundant TFBSs corresponding to
vertebrate TFs of TRANSFAC9.4 [27].
For validation, we obtained another two independent datasets.
One is from Yamada et al [28]. They developed a simple HpaII-
McrBC PCR method to discriminate the methylation status of
CGIs on human chromosome 21q from peripheral blood
leukocytes, and got 103 U-CGIs. As their definition of CGI
(minimum length $400 bp, G+C content $50%, observed/
expected CpG ratio $0.6) is different from ours, we applied our
definition on their U-CGIs and obtained 104 U-CGIs. The other
data is from Schumacher et al [29]. They applied tiling microarray
technology to investigate the profiling of unmethylated sites on
chromosome 21 and 22 in the brain tissue of eight adults
respectively. Combining all the unmethylated regions of eight
samples, we define such CGIs as U-CGIs if there are more than
100 bp overlap between the CGIs and these unmethylated regions.
Finally, we extracted 61 U-CGIs from their data. The background
sequences in the validation are also from M-CGIs as the
methylation-prone data in the original datasets are too insufficient.
Division strategy
In order to identify the sequence features in the U-CGIs, we divided
the U-CGIs and the background CGIs into several 200 bp-long
fragments,and all samples were aligned by the two ends of the CGIs
(Figure 1). Such division strategy is based on the following reasons:
firstly, the median length of the U-CGIs is much longer than
median length of the M-CGIs, in order to avoid bias when
comparing the foreground sequences (U) with the background
sequences (M), we need to divide them into fragments withthe same
length; secondly, all of the CGIs are longer than 200 bp, setting the
fragments to 200 bp would make full use of the samples; thirdly, we
divided the U and the M-CGIs into 6 fragments and 2 fragments
respectively because it would cover most of the sequences although
some U-CGIs are longer than 1200 bp and some M-CGIs longer
than 400 bp. Before this study, we knew that there should be some
sequence features related to the formation of the U-CGIs in their
flanking sequences [52], but we were unclear about how far the
informative flanking sequences would extend. Therefore, we just
arbitrarily extended 1200 bp around the U-CGIs at first, and also
divided them into several 200 bp-long fragments. As there is no
over-represented TFBS between the 800–1200 bp flanking regions,
we only show the fragments in 800 bp flanking regions (Figure 1). It
should be noted that some U-CGIs are less than 1200 bp and some
M-CGIs are less than 400 bp. If any defined CGI fragment extends
out of CGI, such fragment would be eliminated; likewise, if any
fragment of flanking sequences surpasses the given domain, such
fragment would be eliminated as well.
Two-step hypothesis test
After the division processes, we applied MOTIFCLASS [26] to get
the putative TFBSs in every fragment of both types of the CGIs
and their flanking sequences respectively, and counted the number
of samples with given TFBS. Then Fisher’s exact test [53] was
implemented in the U&M-CGIs and their flanking fragments by
comparing (A1, B1, C1) with A2, (F1, E1, D1) with F2, J1 with J2,
I1 with I2, H1 with H2, G1 with G2, K1 with K2, L1 with L2, M1
with M2, and N1 with N2. A TFBS with p-value less than
Bonferroni-adjusted cutoff (0.01) is regarded as a statistically
significant one. In order to filter the influence of the biased G+C
content between U and M, we randomly shuffled fragments of
both the U-CGIs and their boundary sequences for 1000 times,
and compared the shuffled U fragments with M fragments to get
the proportion of samples significantly enriched with given TFBS
in the shuffled U fragments. Similar to a permutation test, we
regard the ratio that the proportion with TFBS in shuffled U
fragments is at least as extreme as the proportion in U fragments in
1000 times as the p-value in the shuffle test. And only the TFBS
with p-value less than 0.01 would be regarded to have no biased
G+C content influence. We define the two step processes as a two-
step hypothesis test. Only the TFBS that is significant in both
hypothesis tests is reported as the significant one.
Novel motif identification
The processing described above only explores the known motifs
(TFBSs). It is also meaningful to identify over-represented novel
motifs in each of the fragment of the U-CGIs and the boundary
sequences. Therefore, we applied DME-b [26] to hunt the novel
motifs with width from 6 to 9 bp. For each motif width, we got the
top 50 enriched motifs as candidate significant motifs. Considering
that there would be some redundancies both between the novel
motifs with different width themselves and between motifs and the
over-represented TFBSs, we used the program Matcompare [54]
to filter all the redundant novel motifs. The parameters of
Matcompare are set as below: the greatest overhang when
comparing motifs is 2, the Kullback-Leibler (K-L) divergence
threshold is set to 1. If two motifs with different width are similar,
the motif with larger width would be kept. In order to filter the
influence of biased G+C content, we also implemented the two-
step hypothesis test on the non-redundant motifs, and the p-value
cutoff in the first step is also Bonferroni-adjusted (0.01).
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The promoter database is from CSHLmpd (http://rulai.cshl.edu/
cshlmpd/). We defined the promoter to be the region between
1 kb upstream and 200 bp downstream of TSS (Transcription
Starting Site). If a CGI overlaps with any promoter region, such
CGI is regarded as promoter-CGI. In the process of identifying
whether the over-represented TFBSs are only the difference
between CGIs in promoter and non-promoter, the ideal method
may be to implement the two-step hypothesis test on promoter-U-
CGIs and promoter-M-CGIs. However, the strongly biased
sample sizes between the promoter-U-CGIs and the promoter-
M-CGIs as well as the small size of the promoter-M-CGIs
compelled us to apply some other methods. We extracted all the
CGIs in human genome and divided them into promoter-CGIs
and non-promoter-CGIs. Then, by sampling data from the CGIs
randomly, we constructed 10 groups of foreground sequences
(promoter related CGIs) and background sequences (non-pro-
moter related CGIs) with the same sample size and composition as
U-CGIs and M-CGIs respectively, i.e. 304 foreground sequences
(297 promoter-CGIs, 7 non-promoter-CGIs) and 210 background
sequences (79 promoter-CGIs, 131 non-promoter-CGIs). The
comparison process between foreground and background se-
quences is the same as U-CGIs vs. M-CGIs.
Conservation analysis
We investigated the conservation information of the over-
represented putative TFBSs among human, mouse and rat. With
the multiple alignment results of human, mouse and rat on UCSC
Genome Browser, we used the 100 bp upstream and downstream
sequences of all the putative binding sites as the input sequences of
PAML [55] to get their phylogenetic tree. Based on the
phylogenetic tree, we applied MONKEY [56] to get the
significance that each putative binding sites are more conserved
among the three species than their flanking sequences. With the p-
value cutoff of 0.01, we calculated the proportion of the
significantly conserved binding sites among the over-represented
putative binding sites.
Chromatin marks information
Barski et al[32] generated a large scale high-resolution profiling of
20 histone methylations in human resting CD4
+ T cells. We
counted the number of each modification in a 200 bp window
sliding with 10 bp offset in the U- and M-CGIs and their flanking
sequences. The average intensity differences of the 20 chromatin
marks in CGIs and 1000 bp flanking sequences between U and M
are calculated at each location. The results are shown in Figure 4.
SUPPORTING INFORMATION
Figure S1 The number of over-represented TFBSs in each
fragment of U-CGIs and their flanking sequences. The x-axis
indicates the location of fragment relative to the 59 or 39 end of U-
CGIs. Thus, fragments insides the two ‘0’s correspond to A1, B1,
C1, D1, E1 and F1 of Figure 1 in the article, and fragments that
are in the 800 bp upstream and downstream of U-CGIs represent
J1, I1, H1, G1 and K1, L1, M1, N1 of Figure 1 in the article
respectively. We applied the Bonferroni-adjusted p-value cutoff
0.05 here.
Found at: doi:10.1371/journal.pone.0001184.s001 (6.81 MB TIF)
Figure S2 The number of over-represented TFBSs in each
fragment of U-CGIs and their flanking sequences. The x-axis
indicates the location of fragment relative to the 59 or 39 end of U-
CGIs. Thus, fragments insides the two ‘0’s correspond to A1, B1,
C1, D1, E1 and F1 of Figure 1 in the article, and fragments that
are in the 800 bp upstream and downstream of U-CGIs represent
J1, I1, H1, G1 and K1, L1, M1, N1 of Figure 1 in the article
respectively. We applied the Bonferroni-adjusted p-value cutoff
0.001 here.
Found at: doi:10.1371/journal.pone.0001184.s002 (6.89 MB TIF)
Figure S3 The number of over-represented TFBSs in each
fragment of U-CGIs located in promoters of unidirectional genes
and their flanking sequences. The x-axis indicates the location of
fragment relative to the 59 or 39 end of U-CGIs. Thus, fragments
insides the two ‘0’s correspond to A1, B1, C1, D1, E1 and F1 of
Figure 1 in article, and fragments that are in the 800 bp upstream
and downstream of U-CGIs represent J1, I1, H1, G1 and K1, L1,
M1, N1 of Figure 1 in article respectively.
Found at: doi:10.1371/journal.pone.0001184.s003 (6.84 MB TIF)
Table S1 The logos of over-represented TFBSs in U-CGIs.
Found at: doi:10.1371/journal.pone.0001184.s004 (0.08 MB
DOC)
Table S2 The logos of over-represented TFBSs in boundaries of
U-CGIs.
Found at: doi:10.1371/journal.pone.0001184.s005 (0.10 MB
DOC)
Table S3 Motifs that are over-represented in U-CGIs. Also
listed are the most similar TFBS to the motif, logo of the TFBS
and their K-L divergence.
Found at: doi:10.1371/journal.pone.0001184.s006 (0.04 MB
DOC)
Table S4 Motifs that are over-represented in the boundary
regions. Also listed are the most similar TFBS to the motif, logo of
the TFBS and their K-L divergence.
Found at: doi:10.1371/journal.pone.0001184.s007 (0.04 MB
DOC)
Table S5 The proportion of the significantly conserved binding
sites in all the over-represented putative binding sites of every TF
in each U-CGI fragment.
Found at: doi:10.1371/journal.pone.0001184.s008 (0.07 MB
DOC)
Table S6 The proportion of the significantly conserved binding
sites in all the over-represented putative binding sites of every TF
in boundary sequences.
Found at: doi:10.1371/journal.pone.0001184.s009 (0.08 MB
DOC)
Table S7 Validation results in the U-CGIs of Yamada et al’s
data. The check mark in the table indicates that the TFBS is
significantly enriched in the specific U-CGI fragment.
Found at: doi:10.1371/journal.pone.0001184.s010 (0.04 MB
DOC)
Table S8 Validation results in boundaries of U-CGIs of Yamada
et al’s data. The check mark in the table indicates that the TFBS is
significantly enriched in the specific boundary region.
Found at: doi:10.1371/journal.pone.0001184.s011 (0.04 MB
DOC)
Table S9 Validation results in the U-CGIs of the Schumacher et
al’s data. The check mark in the table indicates that the TFBS is
significantly enriched in the specific U-CGI fragment.
Found at: doi:10.1371/journal.pone.0001184.s012 (0.04 MB
DOC)
Table S10 Validation results in the boundaries of the U-CGIs of
the Schumacher et al’s data. The check mark in the table indicates
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PLoS ONE | www.plosone.org 9 November 2007 | Issue 11 | e1184that the TFBS is significantly enriched in the specific boundary
region.
Found at: doi:10.1371/journal.pone.0001184.s013 (0.04 MB
DOC)
Table S11 Over-represented TFBSs in M-CGI fragments. The
second column indicates whether the TFs corresponding to the
over-represented TFBSs are expressed in human brain. The logos
of the TFBSs are also given. The two numbers in the 4th-5th
columns are the p-values in the two-step hypothesis test in the
corresponding fragment (we use p1 and p2 to represent the upper
and lower value respectively). Only the TFBS with p1 less than
Bonferroni-adjusted p-value cutoff 0.01 and p2 less than 0.01 is
regarded as a significant TFBS in the fragment, and is marked in
bold. Here we regard TFBSs that are both significant in A2 and F2
fragments as the over-represented TFBSs in M-CGIs. The
redundant TFBSs are eliminated according to MatCompare.
Found at: doi:10.1371/journal.pone.0001184.s014 (0.12 MB
DOC)
Table S12 Over-represented TFBSs in the 400 bp flanking
regions of M-CGI. The second column indicates whether the TFs
corresponding to the over-represented TFBSs are expressed in
human brain. The logos of the TFBSs are also given. The two
numbers in the 4th-5th columns are the p-values in the two-step
hypothesis test in the corresponding fragment (we use p1 and p2 to
represent the upper and lower value respectively). Only the TFBS
with p1 less than Bonferroni-adjusted p-value cutoff 0.01 and p2
less than 0.01 is regarded as a significant TFBS in the fragment,
and is marked in bold. Here we regard TFBSs that are both
significant in O2 and P2 fragments as the over-represented TFBSs
in flanking sequences of M-CGIs.
Found at: doi:10.1371/journal.pone.0001184.s015 (0.05 MB
DOC)
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